Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE 38.49% 35.62% 34.50% 30.63%

+8 more TTM periods
ROA 14.51% 13.90% 13.04% 10.40%
ROIC 37.13% 36.21% 28.66% 75.49%
Return on Tangible Assets 30.24% 25.37% 24.24% 21.48%
Average Days of Receivables 92.38 82.47 95.21 89.68
Free Cash Flow per Share 3.68 3.71 2.76 2.72
Free Cash Flow 1,405.00 1,429.40 1,077.20 1,061.90
Capital Expenditures (343.70) (353.10) (363.50) (386.20)
Piotroski F-Score 7.00 7.00 6.00 5.00
Other line items
Cash ROIC 30.09% 26.95% 24.07% 19.87%
Accounts Receivable Turnover 3.81 4.29 4.20 4.28
Accounts Payable Turnover 0.90 0.99 1.05 1.05
Inventory Turnover 2.88 3.01 3.18 3.11
Average Days of Payables 428.95 408.14 381.46 381.07
Days of Inventory on Hand 142.18 136.50 123.45 119.13
Tax Rate (0.22) (0.23) (0.23) (0.25)
Research and Development Expense of Revenue 12.15% 12.44% 12.85% 13.07%
Selling, General and Administrative Expense of Revenue 27.39% 27.62% 27.69% 28.72%
Share Based Compensation of Revenue 3.27% 3.50% 3.42% 3.72%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 1.75 1.92 1.72 2.01
Depreciation/Fixed assets 0.17 0.17 0.16 0.17
Capex/Depreciation (1.30) (1.36) (1.44) (1.58)
Revenue per Share 13.00 12.51 11.95 11.55
Operating CF per Share 4.58 4.63 3.69 3.70
Capex per Share (0.90) (0.92) (0.93) (0.99)
Capex to Sales 0.07 0.07 0.08 0.09
Net Profit Margin 20.12% 19.31% 17.94% 15.96%

Fold the line items

Columns are period end dates